Absence of mutations in the VHL gene but frequent loss of heterozygosity at 3p25-26 in non-small cell lung carcinomas

Lung Cancer

Volumn 39, Issue 3, 2003, Pages 273-277

  Miyakis, S ^a,c   Liloglou, T ^a,b   Kearney, S ^b   Xinarianos, G ^a,b   Spandidos, D A ^c   Field, J K ^a,b  

^a Roy Castle International Centre for Lung Cancer Research   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

3p; Heteroduplex analysis; Loss of heterozygosity; Non small cell lung cancer; Single strand conformational polymorphism; VHL

Indexed keywords

PROTEIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

AGED; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MUTATION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 3; DNA MUTATIONAL ANALYSIS; GENES, TUMOR SUPPRESSOR; HIPPEL-LINDAU DISEASE; HUMANS; LIGASES; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MIDDLE AGED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0037374420     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00506-8     Document Type: Article

References (18)

1. Latif F., Tory K., Gnarra J., et al. Identification of the von Hippel-Lindau disease tumour suppressor gene. Science. 260:1993;1317-1320.
2. Kaelin W.G. Jr. Molecular basis of the VHL hereditary cancer syndrome. Nat. Rev. Cancer. 2:2002;673-682.
3. Iliopoulos O., Kibel A., Gray S., Kaelin W.G. Jr. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med. 1:1995;822-826.
4. Iliopoulos O., Levy A.P., Jiang C., Kaelin W.G. Jr, Goldberg M. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA. 93:1996;10595-10599.
5. Li X., Lee N.K., Ye Y.W., et al. Allelic loss at chromosomes 3p, 8p, 13q and 17p associated with poor prognosis in head and neck cancer. J. Natl. Cancer Inst. 86:1994;1524-1529.
6. Lounis H., Mes-Masson A.M., Dion F., et al. Mapping of chromosome 3p deletions in human epithelial ovarian tumors. Oncogene. 17:1998;2359-2365.
7. Sekido Y., Bader S., Latif F., et al. Molecular analysis of the the von Hippel-Lindau disease tumour suppressor gene in human lung cancer cell lines. Oncogene. 9:1994;1599-1604.
8. Liloglou T., Maloney P., Xinarianos G., Fear S., Field J.K. Sensitivity and limitations of high throughput fluorescent microsatellite analysis for the detection of allelic imbalance: application in lung tumors. Int. J. Oncol. 16:2000;5-14.
9. Girard L., Zöchbauer-Müller S., Virmani A.K., Gazdar A.F., Minna J.D. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 60:2000;4894-4906.
10. Wistuba I.I., Behrens C., Virmani A.K., et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 60:2000;1949-1960.
11. Fong K.M., Biesterveld E.J., Virmani A., et al. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res. 57:1997;2256-2267.
12. Miyakis S., Sourvinos G., Liloglou T.L., Stathopoulos G.P., Field J.K., Spandidos D.A. The Von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas. Int. J. Cancer. 88:2000;503-505.
13. Kenck C., Wilhelm M., Bugert P., Staehler G., Kovacs G. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas. J. Pathol. 179:1996;157-161.
14. Corless C.L., Kibel A.S., Iliopoulos O., Kaelin W.G. Jr. Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues. Hum. Pathol. 28:1997;459-464.
15. Waber P.G., Lee N.K., Nisen P.D. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the von Hippel-Lindau tumour suppressor gene in head and neck cancer. Oncogene. 18:1996;365-369.
16. Grebe S.K., McIver B., Hay I.D., et al. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J. Clin. Endocrinol. Metab. 82:1997;3684-3691.
17. Hasegawa Y., Takanashi S., Kanehira Y., Tsushima T., Imai T., Okumura K. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with non-small cell lung carcinoma. Cancer. 91:2001;964-971.
18. Williams A., Sun X., Fischer J.E., Hasselgren P.O. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery. 126:1999;744-749.